Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024

BUY
$209.01 - $232.56 $18.3 Million - $20.4 Million
87,733 Added 113.03%
165,350 $36.1 Million
Q4 2023

Feb 14, 2024

SELL
$197.69 - $227.29 $12.3 Million - $14.2 Million
-62,411 Reduced 44.57%
77,617 $17.6 Million
Q3 2023

Nov 13, 2023

SELL
$201.05 - $221.7 $139,528 - $153,859
-694 Reduced 0.49%
140,028 $28.2 Million
Q2 2023

Aug 11, 2023

BUY
$211.93 - $241.33 $1.02 Million - $1.16 Million
4,794 Added 3.53%
140,722 $34 Million
Q1 2023

May 12, 2023

SELL
$213.32 - $257.83 $927,515 - $1.12 Million
-4,348 Reduced 3.1%
135,928 $31.2 Million
Q4 2022

Feb 13, 2023

SELL
$203.72 - $248.97 $6.17 Million - $7.54 Million
-30,281 Reduced 17.75%
140,276 $33 Million
Q3 2022

Nov 10, 2022

SELL
$204.81 - $262.19 $996,605 - $1.28 Million
-4,866 Reduced 2.77%
170,557 $34.9 Million
Q2 2022

Aug 11, 2022

BUY
$213.86 - $277.87 $3.28 Million - $4.26 Million
15,322 Added 9.57%
175,423 $41.1 Million
Q1 2022

May 13, 2022

BUY
$259.82 - $298.18 $10.9 Million - $12.5 Million
42,076 Added 35.65%
160,101 $42.2 Million
Q4 2021

Feb 14, 2022

BUY
$271.6 - $314.21 $5.14 Million - $5.94 Million
18,908 Added 19.08%
118,025 $37.1 Million
Q3 2021

Nov 12, 2021

BUY
$274.82 - $308.34 $4.39 Million - $4.93 Million
15,986 Added 19.23%
99,117 $27.9 Million
Q2 2021

Aug 13, 2021

BUY
$251.87 - $278.14 $9.27 Million - $10.2 Million
36,815 Added 79.49%
83,131 $22.9 Million
Q1 2021

May 14, 2021

SELL
$204.88 - $255.03 $585,342 - $728,620
-2,857 Reduced 5.81%
46,316 $11.8 Million
Q4 2020

Feb 12, 2021

BUY
$186.91 - $214.42 $4.85 Million - $5.56 Million
25,949 Added 111.73%
49,173 $10 Million
Q3 2020

Nov 13, 2020

BUY
$167.03 - $201.3 $3.28 Million - $3.96 Million
19,663 Added 552.18%
23,224 $4.37 Million
Q2 2020

Aug 12, 2020

SELL
$113.31 - $182.44 $203,278 - $327,297
-1,794 Reduced 33.5%
3,561 $592,000
Q1 2020

May 14, 2020

BUY
$104.32 - $195.28 $558,633 - $1.05 Million
5,355 New
5,355 $677,000
Q2 2019

Aug 13, 2019

SELL
$144.16 - $172.9 $3.11 Million - $3.73 Million
-21,565 Closed
0 $0
Q1 2019

May 14, 2019

SELL
$123.7 - $156.3 $18.2 Million - $23 Million
-147,458 Reduced 87.24%
21,565 $3.3 Million
Q4 2018

Feb 13, 2019

BUY
$120.82 - $174.09 $20.4 Million - $29.4 Million
169,023 New
169,023 $21.4 Million
Q4 2017

Feb 13, 2018

SELL
$147.99 - $163.95 $6.31 Million - $6.99 Million
-42,662 Closed
0 $0
Q3 2017

Nov 13, 2017

BUY
$149.47 - $160.56 $6.38 Million - $6.85 Million
42,662
42,662 $6.44 Million

Others Institutions Holding LH

About LABORATORY CORP OF AMERICA HOLDINGS


  • Ticker LH
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 89,600,000
  • Market Cap $21.5B
  • Description
  • Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests,...
More about LH
Track Ray Dalio's Portfolio

Track Ray Dalio Portfolio

Follow Ray Dalio (Bridgewater Associates, LP) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bridgewater Associates, LP, based on Form 13F filings with the SEC.

News

Stay updated on Bridgewater Associates, LP and Ray Dalio with notifications on news.